Due to their precision, high speed (up to 500 CPM) and superior product handling, our cartoning solutions are widely used for secondary packaging of a tablet, capsule, lozenge, pill and suppository blisters.
The TT-600 horizontal cartoner can reach speeds up to 500 CPM, and it is perfect for continuous motion applications. It is available with automatic product transfer, collating devices, extended article bucket conveyors, and product confines.
Tishma Technologies' horizontal cartoners are designed to handle all challenges. We provide State-Of-Art Cartoning automation according to all safety and sanitary standards.
Improve your manufacturing process, achieve the highest possible production quality, and ensure regulatory compliance with fast, reliable, and precise Side Load Cartoner for pharmaceutical blisters that can be integrated with Top-Load Case packer.
Tishma Technologies’ High-Speed Blister Cartoning Machines are built to respond to all current challenges in the pharma industry. In recent years end-of-line packaging has become increasingly complex for pharmaceutical manufacturers, due to changes in serialization requirements on labeling and inspection.
Incorrectly packaged or damaged products could affect patients’ safety and generate expensive recalls, which is why pharmaceutical companies need to take every precaution when it comes to primary and secondary packaging of blister packs.
Blister packs protect pharma products, tablets, capsules, pills or lozenges from humidity, contamination and other external factors, ensuring product integrity of each dose while providing a degree of tamper resistance as well.
To preserve primary packaging integrity and stay compliant with all regulatory requirements, secondary packaging for pharmaceutical blisters requires high-quality packaging equipment.
Increase your efficiency with Tishma Technologies TT-600 Horizontal Cartoner!
See more for Pill And Tablet Blister Secondary Packing Machines: bit.ly/37WisRL
www.tminn.com/
www.nortechpackaging.com/
Tishma Technologies
コメント